PDS Biotechnology
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $43,045,234.

Profit Margin

PDS Biotechnology Corporation (NASDAQ:PDSB): Profit margin
2014 0 -12.20M
2015 0 -28.07M
2016 0 -38.82M
2017 0 -50.85M
2018 0 -40.86M
2019 0 -6.99M
2020 0 -14.84M
2021 0 -16.91M
2022 0 -40.85M
2023 0 -42.94M

PDSB Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0000000000
Cost of revenue
57.32K49.07K246.38K176.29K98.41K0182.91K053.11K0
Gross profit
-57.32K-49.07K-246.38K-176.29K-98.41K0-182.91K0-53.11K0
Operating exp.
Research and development
27.76M29.43M11.25M7.92M6.09M16.06M34.31M24.82M17.83M8.47M
Selling and marketing
264K000000000
Total operating expenses
43.04M41.67M21.43M14.90M17.08M30.35M51.96M39.51M26.49M13.19M
Operating income
-43.04M-41.67M-21.43M-14.90M-21.03M-43.09M-51.96M-39.51M-26.49M-13.19M
Other income (expenses), net
-1.30M-381.33K4.34K55.00K13.65M-12.73M-50.02M-163.46K-2.68M402.12K
Income before tax
-44.34M-42.05M-21.43M-14.84M-7.38M-43.64M-53.44M-40.66M-29.18M-12.79M
Income tax expense
-1.40M-1.19M-4.51M-135.68K-381.51K-2.78M-2.58M-1.84M-1.10M-590.67K
Net income
-42.94M-40.85M-16.91M-14.84M-6.99M-40.86M-50.85M-38.82M-28.07M-12.20M
Earnings per share
Basic EPS
-1.39-1.43-0.66-0.89-1.44-26.16-33.47-26.9-69.43-16.15
Diluted EPS
-1.39-1.43-0.66-0.89-1.44-26.16-33.47-26.9-69.43-16.15
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source